Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
!!Link opens in a new tab
!!Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
First- and second-trimester evaluation of risk for Down syndrome
Robert H. Ball
, Aaron B. Caughey
, Fergal D. Malone
, David A. Nyberg
, Christine H. Comstock
, George R. Saade
, Richard L. Berkowitz
, Susan J. Gross
, Lorraine Dugoff
, Sabrina D. Craigo
, Ilan E. Timor-Tritsch
, Stephen R. Carr
, Honor M. Wolfe
, Danielle Emig
, Mary E. D'Alton
Research output
:
Contribution to journal
›
Article
›
peer-review
89
!!Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'First- and second-trimester evaluation of risk for Down syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
First Trimester
100%
Second Trimester
100%
Risk Evaluation
100%
Down Syndrome
100%
Quad
66%
Pregnancy-associated Plasma protein-A (PAPP-A)
50%
False Positive Rate
50%
Fetus
33%
Nuchal Translucency
33%
Estriol
33%
Inhibin
33%
Down Syndrome Screening
33%
Amniocentesis
33%
Miscarriage
33%
Quality-adjusted Life Years
33%
Maternal Serum alpha-fetoprotein (MSAFP)
33%
High Cost
16%
Screening Test
16%
Live Birth
16%
Sensitivity Analysis
16%
Complication Management
16%
Incremental Cost-effectiveness Ratio
16%
Detection Rate
16%
Triple Screen
16%
Sequential Test
16%
Complications of Care
16%
Quad Screen
16%
Cost Management
16%
Future Policy
16%
Therapeutic Abortion
16%
Societal Costs
16%
Positive Screen
16%
Cost-effective Alternatives
16%
Cost of Care
16%
Sequential Strategy
16%
Down Syndrome Diagnosis
16%
Medicine and Dentistry
Second Trimester Pregnancy
100%
First Trimester Pregnancy
100%
Down Syndrome
100%
Health Care Cost
88%
False Positive Result
33%
Pregnancy-Associated Plasma Protein A
33%
Nuchal Translucency Measurement
22%
Spontaneous Abortion
22%
Maternal Serum
22%
Estriol
22%
Alpha-Fetoprotein
22%
Amniocentesis
22%
Quality Adjusted Life Year
22%
Screening Test
11%
Inhibin A
11%
Sequential Analysis
11%
Therapeutic Abortion
11%
Cost Efficiency
11%
Nursing and Health Professions
Down Syndrome
100%
False Positive Result
33%
Pregnancy Associated Plasma Protein A
33%
Spontaneous Abortion
22%
Amniocentesis
22%
Estriol
22%
Quality Adjusted Life Year
22%
Alpha Fetoprotein Blood Level
22%
Nuchal Translucency Measurement
22%
Live Birth
11%
Screening Test
11%
Cost Utility Analysis
11%
Sequential Analysis
11%
Inhibin A
11%
Therapeutic Abortion
11%